Posts Tagged 'rapamune'

Pfizer CEO’s Pay Rises 23%

pfizer ceo paid millions despite lipitor lawsuitsPfizer Chief Executive Ian Read’s total pay rose 23 percent last year, a Wall Street Journal article reports. Read’s total pay package for 2014 was $23.3 million. The pay increase comes after Pfizer’s board declared Read’s leadership last year to be “outstanding.”

Despite the board’s praise, 2014 was hardly a trouble-free year for the New York–based company. As in previous years, Lipitor lawsuits continued to accumulate against Pfizer. These ...

continue reading...

Pfizer’s Illegal Drug Marketing Charges Settle for $35 million

Pfizer subsidiary Wyeth settles marketing claims for 35 billion dollarsWyeth Pharmaceuticals, a subsidiary of Pfizer, was charged with illegally marketing a drug that was not cleared for use by the FDA. A story in Reuters reports that Wyeth illegally marketed its organ transplant drug Rapamune for conditions it was not approved to treat.

The charges indicated that Wyeth trained and encouraged sales representatives to promote Rapamune for uses other than preventing rejection of ...

continue reading...

Wyeth Pharmaceuticals Pleads Guilty to Criminal Misbranding of Rapamune

On July 31, 2013, the United States Department of Justice announced that Wyeth Pharmaceuticals pleaded guilty to misbranding a drug and agreed to pay $490.9 million to resolve criminal and civil liability. The drug in question, Rapamune, was approved by the FDA in 1999 for use in preventing the body’s immune system from rejecting kidney transplants. Wyeth, however, allegedly trained its U.S. sales force to promote the drug for use in transplants of other organs, something that is ...

continue reading...